Is Trulieve a Buy?
Trulieve Cannabis (OTC: TCNNF)(CNSX: TRUL) has led its shareholders on a wild ride. The stock is up 35% year over year, but now down nearly 50% from its February highs. That's despite the company growing its revenue and operating income less non-cash items (EBITDA) by 78% and 55%, respectively, to $215.1 million and $94.8 million in the second quarter of 2021. So what gives?
As it turns out, Trulieve faces several stumbling blocks ahead, with its growth looking poised to fall off a cliff. So is this a good time to open a stake?
Image source: Getty Images.
Source Fool.com
